Accumulating evidence strongly suggests that RUNX1 promotes tumor aggressiveness in TNBC, while functioning as a tumor suppressor in ER+ breast cancer [18,20,21,22,23,24,25,26,27]. This evidence concerns the gene RUNX1 and neoplasm.